相互作用
Abatacept + Lisocabtagene maraleucel
重症度: 重大
Abatacept and Lisocabtagene maraleucel: major interaction.
最終更新日
医療従事者向け・参照専用。このページは簡潔な要約であり、医学的助言ではなく、公式の添付文書や臨床判断に代わるものではありません。処方・調剤の前に必ず確認してください。
このページの臨床コンテンツは英語でのみ提供されています。
概要
Lisocabtagene maraleucel is a CAR T-cell product, and immunosuppressants such as abatacept may impair CAR T-cell expansion and activity. Both also add to infection risk in patients who are already immunocompromised.
この相互作用をわかりやすく説明すると
Abatacept and Lisocabtagene maraleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Abatacept belongs to Musculoskeletal; Lisocabtagene maraleucel belongs to Oncology.
なぜ起こるのか
Abatacept's T-cell costimulation blockade may suppress CAR T-cell function and adds to overall immunosuppression; the interaction is predicted from mechanism rather than established.
対処法
Stop abatacept before leukapheresis and CAR T infusion where clinically possible, following the product labeling. Monitor closely for infection and for loss of CAR T efficacy if immunosuppression cannot be avoided.
薬剤師に尋ねること
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+会員向け
ページ全体を見る
アカウントを作成してPro+トライアルを始めると、AbataceptとLisocabtagene maraleucelの臨床対応の詳細なアドバイス、追加の注記、エビデンスの詳細、処方全体を対象とした相互作用チェッカーを利用できます。
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
WebでPro+を14日間無料でお試し。カード登録不要。
Abataceptのその他の相互作用
Lisocabtagene maraleucelのその他の相互作用
よくある質問
Can I take Abatacept with Lisocabtagene maraleucel?
MediHelp rates the interaction as major. Abatacept and Lisocabtagene maraleucel can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Lisocabtagene maraleucel is a CAR T-cell product, and immunosuppressants such as abatacept may impair CAR T-cell expansion and activity. Both also add to infection risk in patients who are already immunocompromised.
How serious is the interaction between Abatacept and Lisocabtagene maraleucel?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Stop abatacept before leukapheresis and CAR T infusion where clinically possible, following the product labeling. Monitor closely for infection and for loss of CAR T efficacy if immunosuppression cannot be avoided.
What other medicines interact with Abatacept?
MediHelp also lists interactions of Abatacept with, for example, Adalimumab, Adenovirus types 4 and 7 live, Anakinra. The full list is on the Abatacept page.
完全なモノグラフ、用量、相互作用チェッカーはMediHelpアプリで
MediHelpアプリで、完全なリファレンスを開き、複数薬剤の相互作用をチェックし、用量ツールを利用できます。
